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Medical Imagery
Transient perivascular inflammation of the carotid artery (TIPIC)
syndrome in a patient with COVID-19
A 36-year-old man with moderate-to-severe left neck pain,
local swelling, and tenderness was seen at the emergency room.
Over the prior 4 days he had received beta-lactam antibiotic
therapy with no improvement. One month before he experienced
mild symptomatic coronavirus disease 2019 (COVID-19). The PCR-
based test performed at the emergency room was still positive. The
remaining personal history was negative. The routine laboratory
parameters were within reference range and autoimmunity
screening results were negative (Table 1).
A carotid ultrasonography demonstrated eccentric hypo-/
isoechoic smooth abnormal soft tissue (Figures A-1 and A-2, red
arrows) surrounding the carotid artery bifurcation and in the
proximal internal carotid artery, with a thickness diameter of 5 mm
and median length of 2 cm. No hemodynamically relevant stenosis
or atherosclerotic plaques were present. Nuclear magnetic
resonance confirmed the ultrasonographic findings concerning
the size of the lesion and showed local contrast enhancement, as
well as reactive lymphadenopathy, suggesting a focal vasculitis
(Figures A-3 and A-4, red arrows). Computed tomography
angiography showed no thrombosis or carotid artery dissection
and positron emission tomography did not show pathological
areas of increased uptake along other vessels. The patient received
levofloxacin and painkillers for 5 days. After one month, he was
asymptomatic and a subsequent ultrasonographic exam showed
no alterations of the carotid arteries (Figures B-1 and B-2, red
arrows).
A final diagnosis of transient perivascular inflammation of the
carotid artery (TIPIC) syndrome (previously known as
Table 1
Laboratory results.
Normal value Patient’s value
Rheumatoid factor 0–14 U/mL 6.3
Beta2-microglobulin 0.8–2.4 mg/L 2.3
Interleukin 6 0–7 pg/mL 1.5
ANA Pos 1:160 Negative
IgA EMA Negative Negative
ANCA Negative <1:20 Negative
Anti- MPO Negative <3.5 0.1
Anti-PR3 Negative <2 0.1
ANA, anti-nuclear antibodies; IgA EMA, IgA anti-endomysial antibodies; ANCA,
anti-neutrophil cytoplasmic antibodies; Anti-MPO, anti-myeloperoxidase antibo-
dies; Anti-PR3, anti-proteinase-3 antibodies.
Figure A-1. Axial carotid ultrasonography shows eccentric hypo-/isoechoic smooth
abnormal soft tissue (red arrows) in the proximal internal carotid artery with a
thickness diameter of 5 mm.
Figure A-2. Longitudinal carotid ultrasonography shows eccentric hypo-/isoechoic
smooth abnormal soft tissue (red arrows) surrounding the carotid artery bifurcation
and in the proximal internal carotid artery with a median length of 2 cm.
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“carotidynia”) was made (Lecler et al., 2017). It is believed that this
is the first published case of TIPIC syndrome associated with
COVID-19. SARS-CoV2 causing COVID-19 can promote endothelial
cell infection and inflammation (Varga et al., 2020). The carotid
body could be a site of virus invasion due to local expression of
angiotensin-converting enzyme receptors (Porzionato et al., 2020).
Although no causal relationship between COVID-19 and TIPIC
syndrome could be demonstrated in this patient, this observation
should serve to generate hypotheses and must be confirmed in
future studies with an appropriate design and size.
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Figures A-3 and A-4. Nuclear magnetic resonance shows local contrast enhance-
ment and reactive lymphadenopathy, suggesting a focal vasculitis (red arrows).
Figure B-1 (axial) and B-2 (longitudinal). After one month, carotid ultrasonogra-
phy shows no alterations of the carotid arteries (red arrows).
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